Lentiboost formulated, GMP-grade

Ended Purchase Order Awarded

Contract number
75N90024P00366
Awardee
Awarding agency
Obligated
$21,000

Award facts

Contract value 100% obligated
$21,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Germany

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center awarded a firm-fixed-price purchase order to Sirion Biotech GMBH, a foreign-owned for-profit company, for the delivery of LENTIBOOST formulated, good manufacturing practice (GMP)-grade lentiviral products. The $21,000 contract is to support gene therapy research and patient treatments conducted by the NIH Clinical Center. The award does not include any set-aside designation or subcontractors. Sirion Biotech GMBH, a leading provider of viral vector technologies, will deliver the requested lentiviral reagents from its facilities in Germany by the completion date of May 27, 2024.

Quick answers

Who was awarded contract 75N90024P00366?

75N90024P00366 was awarded to Revvity Gene Delivery GMBH by NIH Clinical Center (National Institutes of Health) on April 26, 2024.

How much is contract 75N90024P00366 worth?

The government has obligated $21,000 on 75N90024P00366.

Was contract 75N90024P00366 competed?

The extent of competition for 75N90024P00366 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login